The beta values for IL-18 and IL-6 were equivalent, whereas considering the critical roles of IL-18 in heart diseases and cardiac hypertrophy, IL-18 may represent a better biomarker that can reflect the development of FC in patients with IVS4+919 G>A mutation. The gene discussed is IL6; the disease is cardiac hypertrophy.